LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications.

    Downs, Callie G / Varisco, Tyler J / Bapat, Shweta S / Shen, Chan / Thornton, J Douglas

    Research in social & administrative pharmacy : RSAP

    2020  Volume 17, Issue 1, Page(s) 2005–2008

    Abstract: ... medical procedures due to COVID-19 impacted the dispensing of opioid and benzodiazepine prescriptions ... writing opioid prescriptions, respectively. Also, the number of patients filling benzodiazepine ... Background: Healthcare access has changed drastically during the COVID-19 pandemic. Elective ...

    Abstract Background: Healthcare access has changed drastically during the COVID-19 pandemic. Elective medical procedures, including routine office visits, were restricted raising concerns regarding opioid and benzodiazepine provider and prescription availability.
    Objective: To examine how the cancelation of elective medical procedures due to COVID-19 impacted the dispensing of opioid and benzodiazepine prescriptions in Texas.
    Methods: Interrupted time series analyses were preformed to examine changes in prescription trends for opioids and benzodiazepines before and after the restriction on elective medical procedures. Samples of patients who filled an opioid or benzodiazepine prescription from January 5, 2020 to May 12, 2020 were identified from the Texas Prescription Monitoring Program. Elective medical procedures were restricted starting March 23, 2020 indicating the beginning of the intervention period.
    Results: Restricting elective procedures was associated with a significant decrease in the number of patients (β = -6029, 95%CI = -8810.40, -3246.72) and prescribers (β = -2784, 95%CI = -3671.09, -1896.19) filling and writing opioid prescriptions, respectively. Also, the number of patients filling benzodiazepine prescriptions decreased significantly (β = -1982, 95%CI = -3712.43, -252.14) as did the number of prescribers (β = -708.62, 95%CI = -1190.54, -226.71).
    Conclusion: Restricting elective procedures resulted in a large care gap for patients taking opioid or benzodiazepine prescriptions.
    MeSH term(s) Analgesics, Opioid/administration & dosage ; Benzodiazepines/administration & dosage ; COVID-19 ; Drug Prescriptions ; Health Policy ; Health Services Accessibility ; Humans ; Interrupted Time Series Analysis ; Practice Patterns, Physicians'/statistics & numerical data ; Prescription Drug Monitoring Programs ; Texas
    Chemical Substances Analgesics, Opioid ; Benzodiazepines (12794-10-4)
    Language English
    Publishing date 2020-06-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2192059-X
    ISSN 1934-8150 ; 1551-7411
    ISSN (online) 1934-8150
    ISSN 1551-7411
    DOI 10.1016/j.sapharm.2020.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications

    Downs, Callie G. / Varisco, Tyler J. / Bapat, Shweta S. / Shen, Chan / Thornton, J. Douglas

    Research in Social and Administrative Pharmacy ; ISSN 1551-7411

    2020  

    Keywords Pharmaceutical Science ; Pharmacy ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.sapharm.2020.06.003
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications

    Downs, Callie G. / Varisco, Tyler J. / Bapat, Shweta S. / Shen, Chan / Thornton, J. Douglas

    Res. Soc. Adm. Pharm.

    Abstract: ... medical procedures due to COVID-19 impacted the dispensing of opioid and benzodiazepine prescriptions ... 8810.40, −3246.72) and prescribers (β = −2784, 95%CI = −3671.09, −1896.19) filling and writing opioid ... Background: Healthcare access has changed drastically during the COVID-19 pandemic. Elective ...

    Abstract Background: Healthcare access has changed drastically during the COVID-19 pandemic. Elective medical procedures, including routine office visits, were restricted raising concerns regarding opioid and benzodiazepine provider and prescription availability. Objective: To examine how the cancelation of elective medical procedures due to COVID-19 impacted the dispensing of opioid and benzodiazepine prescriptions in Texas. Methods: Interrupted time series analyses were preformed to examine changes in prescription trends for opioids and benzodiazepines before and after the restriction on elective medical procedures. Samples of patients who filled an opioid or benzodiazepine prescription from January 5, 2020 to May 12, 2020 were identified from the Texas Prescription Monitoring Program. Elective medical procedures were restricted starting March 23, 2020 indicating the beginning of the intervention period. Results: Restricting elective procedures was associated with a significant decrease in the number of patients (β = −6029, 95%CI = −8810.40, −3246.72) and prescribers (β = −2784, 95%CI = −3671.09, −1896.19) filling and writing opioid prescriptions, respectively. Also, the number of patients filling benzodiazepine prescriptions decreased significantly (β = −1982, 95%CI = −3712.43, −252.14) as did the number of prescribers (β = −708.62, 95%CI = −1190.54, −226.71). Conclusion: Restricting elective procedures resulted in a large care gap for patients taking opioid or benzodiazepine prescriptions.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #505793
    Database COVID19

    Kategorien

To top